Aurinia Pharmaceuticals Inc.

Quick facts

Marketed products

• LUPKYNIS · Immunology / Nephrology
  LUPKYNIS (voclosporin) is a calcineurin inhibitor that suppresses T-cell activation and cytokine production to reduce lupus nephritis inflammation.

Phase 2 pipeline

• Voclosporin High Dose
• Voclosporin Low Dose

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aurinia Pharmaceuticals Inc. portfolio CI brief
• Aurinia Pharmaceuticals Inc. pipeline updates RSS